Megan Billow, DO
Gynecology · Cleveland, OHNPI 1245494848
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $67,525 of the $82,758 with a category attached, or 81.6%. AbbVie accounts for 99.7% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $59,103 and has fallen 99.9% since, to $73 in 2025. Among gynecology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 109 payments — averaging $759.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$82K
- Boston Scientific$131
- Medtronic$40
- Astellas Pharma US Inc$27
- Lupin Inc.$25
- Coopersurgical, Inc.$18
- plus $30 from 2 others
What the payments were for
- Consulting fees$8,32410%
- Speaking & faculty fees$67,52582%
- Travel & lodging$3,9735%
- Food & beverage$2,9034%
- Education$320%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 101 | $82,487 |
| Boston Scientific | 1 | $131 |
| Medtronic | 2 | $40 |
| Astellas Pharma US Inc | 1 | $27 |
| Lupin Inc. | 1 | $25 |
| Coopersurgical, Inc. | 1 | $18 |
| Pfizer | 1 | $17 |
| Therapeuticsmd, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Orilissa$68,337
- ORIAHNN$11,875
- Solyx SIS System$131
How this compares
$82,758 in reported general payments places this provider in the 95th percentile of 77 gynecology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Norethindrone Acetate | 24 | $915 |
Paid to pharmacies, not to this prescriber.
Other gynecology in Cleveland
- Rachel PopeCleveland$49K
- Rosanne Marie KhoCleveland$19K
- Paula EscobarCleveland$5K
- Yolando McGriff ChatmanCleveland$728
- Stephanie ThomasCleveland$477
- Youssef YoussefCleveland$197
- Derek VanamerongenCincinnati$316K
- Joseph FranzeseCincinnati$18K
- Susan Clark-FrantzNorton$10K
- Amber Bondurant SullivanGahanna$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.